GMVDF (G Medical Innovations Holdings) Net Current Asset Value: $-6.64 (As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMVDF G Medical Innovations Holdings Ltd GMVDF
12 GF Score
Price $0.00
View Full Analysis

What is G Medical Innovations Holdings Net Current Asset Value?

G Medical Innovations Holdings GMVDF 12 Net Current Asset Value is $-6.64 as of Dec. 2022. GuruFocus rates GMVDF with a GF Score™ of 12/100.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

G Medical Innovations Holdings's net current asset value per share for the quarter that ended in Dec. 2022 was $-6.64.

The historical rank and industry rank for G Medical Innovations Holdings's Net Current Asset Value or its related term are showing as below:

GMVDF's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.97
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

G Medical Innovations Holdings  (OTCPK:GMVDF) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


G Medical Innovations Holdings Net Current Asset Value Related Terms


G Medical Innovations Holdings Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for G Medical Innovations Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings Net Current Asset Value Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Current Asset Value
Get a 7-Day Free Trial -0.04 -0.05 -0.01 -20.61 -6.64

G Medical Innovations Holdings Semi-Annual Data
Sep16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 4.16 -20.61 -12.27 -6.64

GMVDF vs WHSI, ISRG, BDX: Net Current Asset Value Comparison

For the Medical Devices subindustry, G Medical Innovations Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's Price-to-Net-Current-Asset-Value falls into.


GMVDF
12GF Score
G Medical Innovations Holdings Ltd GMVDF
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G Medical Innovations Holdings Net Current Asset Value Calculation

G Medical Innovations Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net Current Asset Value Per Share(A: Dec. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.993-9.396-2.782-0)/1.533
=-6.64

G Medical Innovations Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2022 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.993-9.396-2.782-0)/1.533
=-6.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of $-6.64 mean?
G Medical Innovations Holdings (GMVDF) has a Net Current Asset Value of $-6.64 as of Dec. 2022. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on G Medical Innovations Holdings and its competitors.
Is G Medical Innovations Holdings' Net Current Asset Value too high?
G Medical Innovations Holdings' current Net Current Asset Value is $-6.64. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' Net Current Asset Value compare to WHSI and ISRG?
G Medical Innovations Holdings' Net Current Asset Value of $-6.64 can be compared against companies in the Medical Devices & Instruments industry. The industry median Net Current Asset Value is 4.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.97, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on G Medical Innovations Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. G Medical Innovations Holdings's current Net Current Asset Value is $-6.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current Net Current Asset Value of $-6.64. The current Net Current Asset Value is $-6.64. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current Net Current Asset Value is $-6.64 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G Medical Innovations Holdings Business Description

Address 5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score

Get the complete analysis for GMVDF

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price